State-owned pharmaceutical company PT Kimia Farma has temporarily halted the distribution of Biozek rapid test kits following controversy surrounding the kits' accuracy and country of origin.

The publicly listed company said in a statement on Wednesday that it was seeking clarification from the supplier, Dutch firm Inzek International Trading BV, on the kits' manufacturer and accuracy rate following recent findings by Tempo and the Organized Crime and Corruption Reporting Project (OCCRP).